Full length articlePolysaccharide-based films for the prevention of unwanted postoperative adhesions at biological interfaces
Graphical abstract
Introduction
Postoperative adhesions are a major complication to otherwise successful surgeries [1], [2], [3], [4], [5], [6], [7], [8]. Despite tremendous efforts to resolve this unwanted scar formation, there exists no consistently efficacious and safe solution [2,4,9,10]. Adhesions form in the normal, acute phase of injury, and resolve in an equilibrium state between fibrin deposition and fibrinolysis until the injury site has healed [11], [12], [13]. However, these fibrinous strands may remain well beyond the healing period and tether tissues that are normally separated, causing chronic pain and even loss of function, such as secondary female infertility and bowel obstruction affecting the quality of life of the patients [2,5,10,[14], [15], [16], [17]]. Adhesion formation occurs in up to 90% of abdominopelvic procedures [8], requiring additional surgical interventions in over 33% of patients [18] which presents huge costs to the healthcare system (in excess of $3.45 billion (US) annually in the USA) [19], [20], [21], [22].
Efforts to resolve unwanted adhesions have included improvements in surgical techniques [23], pharmaceutical methods [24], and barrier devices to mechanically separate tissues [3]. Mechanical devices have had the greatest success of any adhesion prevention method [13,25]. These devices include sprays, gels, solutions, in situ gelling polymers, and pre-formed membranes made from natural and synthetic polymers [10,26].
A variety of adhesion prevention devices made from natural and synthetic polymeric materials have reached the Food and Drug Administration (FDA) approval. One of which is Seprafilm® (Sanofi, Paris, France), a pre-formed hydrogel membrane consisting of carboxymethylcellulose (CMC) and chemically modified HA. Despite its efficacy, the use of Seprafilm® is limited owing to its handling issues [27], [28], [29]. A dry Seprafilm is too brittle, sticks to tools, and is not repositionable; and the wet film has poor mechanical integrity and cannot be manipulated [2,10]. Interceed® (Gynecare, Ethicon, Somerville, NJ) made from oxidized regenerated cellulose has mixed reviews with some studies indicating adhesion induction [30] and limited efficacy in incomplete hemostasis [4]. Liquid based antiadhesion formulations like Adept™ (Baxter, Unterschleissheim, Germany) made of 4% icodextrin, is sutureless and can be administered laparoscopically, but its fluidity causes leakage from the surgical site with limited adherence to designated regions [31]. Some gels and in situ gelling formulations as adhesion barriers initially received much enthusiasm because of their ability to conform to tissue geometries and delivery via laparoscopy. However, injectable gels that are cross-linkable in situ were less favorable because of long gelling times and assistance required from external devices [2,[32], [33], [34], [35]]. The liquid based anti-adhesion agents are limited in their scope because they require complicated procedures to spray at the targeted site [31] and have failed due to dilution with bodily fluids and migration from the injury site [13], and crosslinked injectable gels such as HyalobarrierⓇ (Anika Therapeutics, S.r.l., Abano Terme, Italy) may be hindered by uneven distribution at the injury site [36].
An ideal anti-adhesion barrier should have the following attributes: be pliable, robust enough to withstand operating room procedures including laparoscopic delivery; maintain mechanical integrity to facilitate repositioning within the surgical field; conform to delicate tissue geometries; be mucoadhesive to avoid the need for sutures and staples; and have appropriate retention time to effectively prevent unwanted adhesions during the critical healing period of 3–7 days [37], [38], [39].
In this study, we present a pre-formed hydrogel membrane composed of HA and alginate, both are natural polysaccharides well established for wound healing and anti-adhesion [40], [41], [42], [43], [44], [45], [46]. The distinguishing feature of this membrane is a fibrillar ultrastructure attained by use of a sacrificial porogen (urea crystals) that imparts toughness and elasticity to the films. This ultrastructure is obtained by combining a photoreactive HA derivative, glycidyl methacrylate-hyaluronic acid (GMHA), alginate, and urea in aqueous solution. The solution is then cast into thin films, dried and nucleated with a urea seed crystal to initiate the growth of microscopic, branch-like urea crystals throughout the membrane. This in situ crystallization process compresses the polymers into microfibers [47], which are then stabilized by crosslinking with UV light and calcium chloride. Thoroughly rinsing the films with water washes away the urea crystals, leaving behind an interconnected porous network running alongside the fibers. This simple processing method does not require expensive equipment, software programming and is readily scalable. Furthermore, the resulting toughness and elasticity can be modified by tuning the membrane composition and crosslink density.
The alginate component in this membrane undergoes a gradual gel-to-mucoadhesive transition. Calcium ions responsible for gelation of the alginate are replaced with sodium ions, causing dissolution of the alginate into a mucous material [46]. This dissolution permits brief repositioning of the membranes in the surgical field, as well as subsequent mucous adherence to tissues.
The proposed innovative membrane solves the limitations of the existing anti-adhesion devices. This pre-formed membrane is easy to handle, can be manipulated while wet, is mucoadhesive, and can successfully prevent unwanted adhesions at a biological interface. Additionally, this membrane can be laparoscopically delivered, and requires no additional equipment or suturing. The unique fibrillar ultrastructure contributes to better mechanical and handling properties. In addition, the porosity within the membrane facilitates the diffusion of water, nutrients and oxygen through the large surface area [48]. The form and mechanical characteristics of this adhesion barrier provide the foundation for excellent product efficacy.
Section snippets
Materials
Medical grade sodium alginate Pronova UP LVG: 120 kDa, M/G ratio 0.67 was purchased from FMC Novamatrix (Sandvika, Norway). High molecular weight sodium hyaluronate from Streptococcus equi. with molecular weight 1.6 × 106 Da was obtained from Sigma-Aldrich (St. Louis, MO, USA). Bacteria-derived high molecular weight sodium hyaluronate was also received from Genzyme, as a generous gift (1.6 × 106 MDa, Genzyme, Cambridge, MA, USA). Urea in the form of small round crystalline pellets was obtained
Film preparation
The successful modification of HA with glycidyl methacrylate (Fig. S1) was confirmed by NMR (Fig. S2). Optionally a simple method of imparting macropores within the films using urea crystals as sacrificial porogens (adapted from previously reported methodologies) [47] was employed, and TGA was used to confirm the removal of urea and other water soluble components (e.g. initiator and water soluble polymers not crosslinked to the films) from the films after extensive washing (Fig. S3); urea is a
Conclusions
Here we present polysaccharide membranes with anti-adhesive properties that address a specific clinical need for materials that are easy to handle and deter/prevent postoperative adhesions between biological interfaces. A simple, bench-top process using urea as a sacrificial porogen enabled the creation of macropores within three-dimensional alginate/GMHA films. The resulting films that are more malleable and tougher than equivalent films produced without the sacrificial porogen. In a rat
Declaration of Competing Interest
The authors report no conflicts of interest in this work.
Acknowledgments
We thank Vidhi Maheshwari (PhD) at Alafair Biosciences, Austin, TX for editorial contributions to the manuscript. We thank Steve Sorey in the Department of Chemistry at the University of Texas, Austin for his assistance in acquisition of NMR spectra. We thank Jawad Ali (MD), Carlos Brown (MD) and John Uecker (MD) at the Seton Family of Hospitals (TX, USA) for assistance with evaluation of adhesions on a 4-point subjective scale.
Disclosure
The authors report no conflicts of interest in this work.
Funding Sources
This study was supported by National Science Foundation Division of Materials Research Grant 0805298 and NIH STTR Phase 1/II Fasttrack grant (4R42GM103158-02).
References (69)
- et al.
Peritoneal adhesions and their relation to abdominal surgery. A postmortem study
Am. J. Surg.
(1973) - et al.
Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study
Lancet
(1999) - et al.
Polymer materials for prevention of postoperative adhesion
Acta Biomater.
(2017) - et al.
Abdominal adhesions: current and novel therapies
J. Surg. Res.
(2011) Contemporary adhesion prevention
Fertil. Steril.
(1994)- et al.
In situ cross-linkable hyaluronic acid hydrogels prevent post-operative abdominal adhesions in a rabbit model
Biomaterials
(2006) - et al.
Evaluation of a fibrin preparation containing tranexamic acid (Adhexil) in a rabbit uterine horn model of adhesions with and without bleeding and in a model with two surgical loci
Fertil. Steril.
(2010) - et al.
Current strategies and future perspectives for intraperitoneal adhesion prevention
J. Gastrointest. Surg.
(2012) - et al.
Crosslinked hyaluronan hydrogels containing mitomycin C reduce postoperative abdominal adhesions
Fertil. Steril.
(2005) - et al.
Seprafilm (modified hyaluronic acid and carboxymethylcellulose) acts as a physical barrier
Fertil. Steril.
(2003)
Injectable thermosensitive hydrogel containing hyaluronic acid and chitosan as a barrier for prevention of postoperative peritoneal adhesion
Carbohydr. Polym.
In situ cross-linkable hyaluronic acid hydrogels prevent post-operative abdominal adhesions in a rabbit model
Biomaterials
Prevention of peritoneal adhesions with an in situ cross-linkable hyaluronan hydrogel delivering budesonide
J. Control. Release
Photocrosslinkable gellan gum film as an anti-adhesion barrier
Carbohydr. Polym.
Evaluation of the ability of xanthan hum/gellan gum/hyaluronan hydrogel membranes to prevent the adhesion of postrepaired tendons
Carbohydr. Polym.
Biodegradable and injectable in situ cross-linking chitosan-hyaluronic acid based hydrogels for postoperative adhesion prevention
Biomaterials
Alginate-PEGAc: a new mucoadhesive polymer
Acta Biomater.
Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications
Carbohydr. Polym.
Crystal templating dendritic pore networks and fibrillar microstructure into hydrogels
Acta Biomater.
Rapid temperature/pH response of porous alginate-g-poly(N-isopropylacrylamide) hydrogels
Polym. Commun.
Influence of the degree of methacrylation on hyaluronic acid hydrogels properties
Biomaterials
Mechanical properties of gelatin films cross-linked, respectively, by ferulic acid and tannin acid
Food Hydrocoll.
Studies on the physical properties of mixed pectin/ethylcellulose films intended for colonic drug delivery
Int. J. Pharm.
Electrically treated composite films based on chitosan and methylcellulose blends
Food Hydrocoll.
Design and evaluation of bilayered buccal film preparations for local administration of lidocaine hydrochloride
Eur. J. Pharm. Biopharm.
Anisotropy in tensile and ductile–brittle transition behavior of ODS ferritic steels
J. Nucl. Mater.
Comparison of the two types of bioresorbable barriers to prevent intra-abdominal adhesions in rats
J. Gastrointest. Surg.
A direct comparison of Seprafilm, adept, intercoat, and spraygel for adhesion prophylaxis
J. Surg. Res.
Preparation and characterization of branched polymers as postoperative anti-adhesion barriers
Appl. Surf. Sci.
Effect of polylactic film (Surgi-Wrap) on preventing postoperative ileus after major hepato-pancreato-biliary surgery
Ann. Hepatobiliary Pancreat. Surg.
Review of the pathophysiology and management of postoperative ileus
World J. Surg.
A review of the problematic adhesion prophylaxis in gynaecological surgery
Arch. Gynecol. Obstet.
Intestinal obstruction from adhesions–how big is the problem?
Ann. R. Coll. Surg. Engl.
The use of silver foil to prevent adhesions in brain surgery
JAMA
Cited by (35)
Polysaccharide-based hydrogels for medical devices, implants and tissue engineering: A review
2024, International Journal of Biological MacromoleculesRecent advances in the preventative strategies for postoperative adhesions using biomaterial-based membranes and micro/nano-drug delivery systems
2023, Journal of Drug Delivery Science and Technology